LONG-TERM ENALAPRIL - A NEW CONVERTING-ENZYME-INHIBITOR - IN THE TREATMENT OF MILD TO MODERATE ESSENTIAL-HYPERTENSION, RESULTS OF A WORLDWIDE MULTICLINIC STUDY - COMPARING 2 WAYS OF ANALYZING DATA

被引：15

作者：

LESSEM, JN

RUCINSKA, E

VICKERS, FF

ESPIE, J

SROMOVSKY, JA

机构：

[1] MERCK SHARP & DOHME RES LABS, RAHWAY, NJ 07065 USA

[2] UNIV LUND, DEPT GERIATR, S-22101 LUND, SWEDEN

来源：

CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 1985年 / 7卷 / 11期

关键词：

D O I：

10.3109/10641968509073607

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1515 / 1539

页数：25

共 52 条

[1]

AMANN FW, 1980, LANCET, V1, P150

[2]

[Anonymous], 1971, STAT PRINCIPLES EXPT

[3]

ATKINSON AB, 1980, LANCET, V2, P105

[4]

BEEVERS D G, 1984, British Journal of Clinical Pharmacology, V18, P51

[5]

BERGSTRAND R, 1982, BRIT J CLIN PHARMACO, V14, pP136

[6] ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].

BIOLLAZ, J ;

SCHELLING, JL ;

COMBES, BJD ;

BRUNNER, DB ;

DESPONDS, G ;

BRUNNER, HR ;

ULM, EH ;

HICHENS, M ;

GOMEZ, HJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368

[7] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].

BRAVO, EL ;

TARAZI, RC .

HYPERTENSION, 1979, 1 (01) :39-46

[8] PROTEINURIA DURING LONG-TERM CAPTOPRIL THERAPY [J].

CASE, DB ;

ATLAS, SA ;

MOURADIAN, JA ;

FISHMAN, RA ;

SHERMAN, RL ;

LARAGH, JH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (04) :346-349

[9] ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL [J].

CHRYSANT, SG ;

BROWN, RD ;

KEM, DC ;

BROWN, JL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :741-746

[10] HEMODYNAMICS OF ORALLY-ACTIVE CONVERTING ENZYME-INHIBITOR (SQ 14225) IN HYPERTENSIVE PATIENTS [J].

CODY, RJ ;

TARAZI, RC ;

BRAVO, EL ;

FOUAD, FM .

CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 (05) :453-459

← 1 2 3 4 5 6 →